相关实验视频

Updated: Jul 13, 2025

Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells

Generation of Recombinant Human IgG Monoclonal Antibodies from Immortalized Sorted B Cells

Published on: June 5, 2015

在肌痛性骨髓灰质炎治疗里图克西马布

Ana Vesperinas-Castro^1,2,3,4, Elena Cortés-Vicente^1,2,3,4

¹Neuromuscular Diseases Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.

Frontiers in neurology

|October 18, 2023

概括

利图西马布为耐火性肌痛性肌痛症 (MG) 提供了潜在的治疗方法,特别是在MuSK阳性患者中. 然而,它的有效性在ACHR阳性,血清阴性和青少年MG中各不相同,需要进一步研究最佳使用情况.

科学领域:

神经学神经学
免疫学免疫学免疫学
药理学药理学是指药理学的学科.

背景情况:

骨髓灰质炎 (MG) 是一种慢性自身免疫性神经肌肉结合障碍.
针对突触后蛋白质的抗体导致MG,10-30%的患者对标准疗法没有反应.
利图西马布是一种向CD20的单克隆抗体,用于非标签的耐火性MG.

研究的目的:

审查有关利图西马布在各种肌痛性骨髓灰质炎亚型中的有效性的现有证据.
总结最优的管理方案,监测策略和Rituximab在MG中的安全性概况.
为了解决现有研究报告的治疗结果的变化.

主要方法:

对MG中rituximab的观察性研究和临床试验的系统文献综述.
分析了根据MG亚型分层的疗效数据 (MuSK阳性,ACHR阳性,血清阴性,青少年).
评估报告的服用方案,监测方法和不良事件.

主要成果:

利图西马布在MuSK阳性MG中显示出明显的好处.
在ACHR阳性MG患者中观察到可变和不一致的结果.
有限的证据表明,rituximab在血清阴性和青少年MG的疗效,关于最佳治疗策略的开放问题.

结论:

利图西马布是耐火性MuSK阳性MG的一个有价值的选择.
需要进一步的研究,以建立最佳的Rituximab协议用于ACHR阳性,血清阴性和青少年MG.
关于施用,监测和安全性的全面数据对于扩大Rituximab在MG管理中的作用至关重要.

关键词:

B细胞的枯竭导致B细胞的枯竭.里图西马布 (Rituximab) 是一种药物.有效性和安全性和安全性.骨髓灰质炎 (骨髓灰质炎MG)不耐药的患者.

更多相关视频

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

Antigenic Liposomes for Generation of Disease-specific Antibodies

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

相关概念视频

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...

Myasthenia Gravis: Diagnostic Tests

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...

Rheumatic Heart Disease III: Medical Management

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...

Myocarditis III: Medical Management

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...